Eiko Lifesciences Ltd Share Price

Q: What is the share price of Eiko Lifesciences Ltd today?

Eiko Lifesciences Ltd share price as on 14 Jul 2026 is ₹52.0

Chemicals

BSE: 540204 Small Cap ISIN: INE666Q01016

As on 15 July 2026 at 01:40 IST

₹52

+ 0.21

(0.41%)

Sell Buy

Over 1 Month

4.88%

Over 6 Months

-5.27%

Over 1 Year

2.55%

Over 3 Years

-11.21%

Eiko Lifesciences Ltd Summary

Close ₹51.79

Open ₹51.50

High ₹53

Low ₹50.75

Volume 7,175

Net Turnover (in Cr) ₹0.037

52Wk High ₹65.90

52Wk Low ₹45.90

52Wk High / Low

45.90

65.90

Eiko Lifesciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹74.30

EPS (TTM) 2.50

Book Value (BV) 47.05

Div. Yield -

P/E (TTM) 20.72

Price/Book Value 1.10

Delivery % 68.70 %

Face Value 10

Key Ratios

PE Ratio 41.53

PB Ratio 1.28

EV to Sales 1.70

PEG Ratio 0.35

ROA 2.99

ROE 2.75

Debt-Equity 0.02

Net Profit Margin 4.52

Operating Profit Margin 8.37

Eiko Lifesciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2020	FY 2019	FY 2018
Total Revenue	38.38	10.41	4.30	2.40
Total Expenses	35.80	15.34	5.30	2.16
Profit Before Tax	3.06	-4.93	-1	0.25
Profit After Tax	2.32	-3.62	-0.78	0.20
Operating Profit After Depreciation	2.74	-4.71	-0.82	0.33

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2020	FY 2019	FY 2018
Fixed Assets	23.12	1.75	1.71	1.68
Total Non Current Assets	33.22	7.03	5.13	4.98
Total Current Assets	32.88	5.03	4.17	5.98
Total Assets	66.10	12.05	9.31	10.95
Total Shareholder's Fund	56.79	2.95	4.92	5.56

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2020	FY 2019	FY 2018	FY 2017
Net Cash From Operating Activities	2.92	-0.33	0.16	-	-
Net Cash Used In Investing Activities	-11.44	-0.71	-0.30	-	-
Net Cash Used In Financing Activities	6.96	0.95	-0.55	-	-

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	33.52	28.11	19.18	26.09	12.45
Total Expenses	31.54	27.12	18.15	25.14	11.62
Profit Before Tax	2.32	0.98	1.03	0.94	0.83
Profit After Tax	1.74	0.75	0.77	0.71	0.61
Operating Profit After Depreciation	2.10	1.13	1.18	1.41	0.92

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	14.26	13.57	13.88	14.29	0.25
Total Non Current Assets	31.96	21.81	21.74	22.46	5.91
Total Current Assets	28.42	30.93	9.30	12.44	10.70
Total Assets	60.37	52.74	31.04	34.89	16.61
Total Shareholder's Fund	56.42	50.68	29.42	28.63	12.53

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	2.05	-7.08	4.22	-7.73	-0.83
Net Cash Used In Investing Activities	-9.85	-0.55	0.87	0.59	-2.94
Net Cash Used In Financing Activities	5.97	20.36	-4.70	3.28	7.81

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	18.34	11.98	11.67	10.71	11.27
Total Expenses	16.09	10.10	9.90	9.20	9.96
Profit Before Tax	2.01	1.90	1.71	1.48	1.63
Profit After Tax	1.50	1.43	1.28	1.11	1.24
Operating Profit after Depreciation	2.38	2.23	2.07	1.78	1.61

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	15.90	9.57	9.20	7.45	7.09
Total Expenses	14.68	8.70	8.47	6.93	6.58
Profit Before Tax	1.48	1.24	1.07	0.90	1.19
Profit After Tax	1.12	0.95	0.82	0.69	0.90
Operating Profit after Depreciation	1.67	1.43	1.29	1.07	1.04

Eiko Lifesciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 50.69

S2 49.60

S3 48.44

Pivot 51.85

R1 52.94

R2 54.10

R3 55.19

Moving Average

20 SMA 51

50 SMA 50.92

100 SMA 51.43

200 SMA 52.23

Eiko Lifesciences Ltd Corporate Actions

No available data

AGM Date: 28 Sep 2021

AGM 28/09/2021 1. The Board''s Report, Corporate Governance Report, Management and Discussion and Analysis Report. 2. Draft notice convening 44th Annual General Meeting of the Members of the Company to be held on Tuesday, 28th September 2021 at 4.30 P.M. at the registered office of the Company through Video - Conferencing ('VC') /Other Audio Visual Means ('OAVM'). 3. Wednesday, September 22, 2021, as the cut-off date to determine the entitlement of voting rights of members for E-voting. 4. Annual Report of the Company for the period ended on March 31st, 2021. 5. The closure of Register of Members and Share Transfer Books of the Company from Wednesday, September 22, 2021, to Tuesday, September 28, 2021 (both days inclusive) for the purpose of Annual General Meeting. 6. The remote e-voting period for 44th AGM begins on Saturday, 25th September 2021 at 9.00 AM IST and ends on Monday, 27th September 2021 at 5.00 PM IST. Summary of proceedings of the 44th Annual General Meeting of the Company held on Tuesday 28th day of September 2020 at 4.30 p.m. Indian Standard Time (IST). (As Per BSE Announcement Dated on 9/29/2021 12:55:18 PM) Please take note of the results of voting (including e-voting) at Annual General Meeting held on Tuesday September 28 2021 alongwith scrutinizers report (As Per BSE Announcement Dated on 9/30/2021 4:05:52 AM) Please take note of the results of voting (including e-voting) at Annual General Meeting held on Tuesday September 28 2021 alongwith scrutinizers report (As Per BSE Announcement Dated on 10/7/2021 3:57:01 AM)

AGM Date: 25 Jun 2022

We wish to inform you that 45th (Forty-fifth) Annual General Meeting of Members of Eiko LifeSciences Limited [Formerly known as Narendra Investments (Delhi) Limited] will be held on Saturday, 25th day of June, 2022 at 11.30 A.M.(IST) through Video Conference ('VC')/Other Audiovisuals Means ('OAVM'), in accordance with the MCA Circular No. 20/2020 dated 05 May, 2020 and Circular no. 02/2021 dated 13 January, 2021 read with Circular Nos. 14/2020 and 17/2020 dated 08 April, 2020 and 13 April, 2020 respectively and Circular No 21/2021 dated 14 December, 2021 (collectively referred to as''MCA Circulars'') and ''SEBI vide its CircularNo.SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated 12 May, 2020 and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated 15 January, 2021 (collectively referred to as ''SEBI Circulars'').Accordingly Notice of 45th Annual General Meeting along with explanatory statement is enclosed for the information of stock exchanges. We request you to take the same on your records The Board has considered and approved the following. 1.The Board''s Report, Corporate Governance Report, Management and Discussion and Analysis Report. 2.Draft notice convening 45th Annual General Meeting of the Members of the Company to be held on Saturday, 25th June 2022 at 11.30 A.M. at the registered office of the Company through Video - Conferencing ('VC') /Other Audio-Visual Means ('OAVM'). 3.Monday, June 20, 2022, as the cut-off date to determine the entitlement of voting rights of members for E-voting. 4.Annual Report of the Company for the period ended on March 31st, 2022. 5.The closure of Register of Members and Share Transfer Books of the Company from Monday, June 20, 2022, to Saturday, June 25, 2022 (both days inclusive) for the purpose of Annual General Meeting. 6.The remote e-voting period for 45th AGM begins on Wednesday, 22nd June 2022 at 9.00 AM IST and ends on Friday, 24th June 2022 at 5.00 PM IST. (As Per BSE Announcement Dated on 01.06.2022) Summary of proceedings of the 45th Annual General Meeting of the Company held on Saturday, 25th day of June, 2022 at 11.30 a.m. Indian Standard Time (''IST''). (As Per BSE Announcement Dated on 25.06.2022) Please take note of the results of voting (including e-voting) at Annual General Meeting held on Saturday, June 25, 2022 alongwith scrutinizer''s report (As Per BSE Announcement Dated on 27/06/2022) Eiko Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 29/06/2022)

AGM Date: 23 Sep 2023

The Board has considered and Approved the following- 1. The Board''s Report, Corporate Governance Report, Management Discussion and Analysis Report. 2. Draft notice convening 46th Annual General Meeting of the Members of the Company to be held on Saturday, 23rd September 2023 at 12.30 p.m. (IST) at the registered office of the Company through Video - Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). 3. Friday, September 15, 2023, as the cut-off date to determine the entitlement of voting rights of members for E-voting. 4. Annual Report of the Company for the period ended on 31st March 2023. 5. The remote e-voting period for 46th AGM begins on Wednesday, 20th September 2023 at 9.00 a.m. (IST) and ends on Friday 22nd September 2023 at 5.00 p.m. (IST) Pursuant to Regulation 30 of the SEBI Listing Regulations read with Part A of Schedule III, please find enclosed herewith proceeding of Forty-Sixth Annual General Meeting of the Company held today i.e., Saturday, September 23, 2023 at 12:30 PM through Video Conferencing (VC)/ Other Audio-Visual means (OVAM) (As Per BSE Announcement Dated on 23/09/2023)

AGM Date: 28 Sep 2024

Newspaper Publication Proceedings of Annual General Meeting (As per BSE Announcement Dated on 28/09/2024) Voting Results and Scrutinizer Report (As per BSE Announcement dated on 30/09/2024)

AGM Date: 05 Sep 2025

AGM 05/09/2025 Approved Notice of 48th Annual General Meeting of the Company of the Members ofthe Company to be held on Friday, 05 September, 2025 at 04:00 pm through Video Conferencing/Other Audio-Visual Means. Notice of AGM to be held on 05th September, 2025 at 04:00 PM IST (As Per BSE Announcement Dated on :31.07.2025) Proceedings of 48th Annual General Meeting of the Company. (As Per BSE Announcement Dated on:05.09.2025) Combined e-Voting Results alongwith Scrutinizer''s Report. (As Per BSE Announcement Dated on:06.09.2025)

Eiko Lifesciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Pidilite Industries Ltd	₹1,498.80	₹1,52,544.17
SRF Ltd	₹2,658.95	₹78,817.88
Linde India Ltd	₹6,709.95	₹57,222.45
Gujarat Fluorochemicals Ltd	₹3,680.65	₹40,431.94
Navin Fluorine International Ltd	₹7,186.40	₹36,863.93

Eiko Lifesciences Ltd Top Mutal Funds Invested

No data available

Eiko Lifesciences Ltd News

Eiko Lifesciences schedules board meeting

On 26 May 2026

22 May 2026, 05:45 pm

Eiko Lifesciences to convene board meeting

On 29 January 2026

17 Jan 2026, 10:03 am

Eiko Lifesciences to conduct EGM

On 7 January 2026

11 Dec 2025, 07:25 pm

Eiko Lifesciences to hold board meeting

On 11 December 2025

09 Dec 2025, 10:14 am

Eiko Lifesciences to hold board meeting

On 31 October 2025

17 Oct 2025, 03:44 pm

Eiko Lifesciences Ltd Stock Analysis

Annual revenue for Eiko Lifesciences Ltd increased by 19.25% to ₹33.52 crore in FY 2025 from ₹28.11 crore in FY 2024.
Annual Net Profit for Eiko Lifesciences Ltd increased by 131.64% to ₹1.74 crore in FY 2025 from ₹0.75 crore in FY 2024.
Promoter Shareholding in Eiko Lifesciences Ltd remains unchanged by 0.00% in the most recent quarter, from 39.91% in February 2026 to 39.91% in March 2026.
Eiko Lifesciences Ltd delivered a 1-year return of 2.55% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Eiko Lifesciences Ltd share price moved up by 0.41% from its previous close of INR ₹51.79. The latest Eiko Lifesciences Ltd share price is INR ₹52.
Eiko Lifesciences Ltd share price today has been at a low of 52 and a high of 52. Over the past 52 weeks, the Eiko Lifesciences Ltd share price has seen a low of 45.90 and a high of 65.90.